Literature DB >> 12297335

Osteoclastogenic potential of bone marrow cells increases with age in elderly women with fracture.

Yasuko Koshihara1, Ayako Suematsu, Dongyun Feng, R Okawara, H Ishibashi, S Yamamoto.   

Abstract

The most reliable explanation for decreasing bone mass in elderly women is an imbalance of osteoclastic resorption and osteoblastic formation resulting from a relative increase in osteoclastic resorption. However, it is not clear whether an increase in osteoclastic bone resorption with age is due to increased osteoclast formation or to osteoclastic bone resorption activity. In this study, using a human bone marrow culture system, we attempt to clarify the increase in osteoclast formation with age. The mononuclear cell-rich fraction from bone marrow, obtained from the proximal region of the femur from female elderly patients with fracture, were cultured for 14 days in the presence of 1,25 dihydroxyvitamin D(3). Tartrate-resistant acid phosphatase-positive multinucleated cells were counted as osteoclasts. In our investigation, human osteoclast formation in the bone marrow culture increased with age in elderly women (age 64-96 years). The osteoclast formation was positively correlated with macrophage-colony stimulation factor and prostaglandin E(2) production in bone marrow culture. Also, osteoclast formation ex vivo was negatively correlated with bone mineral density of the lumbar spine (L2-L4). The above results indicate that the osteoclastogenic potential of bone marrow cells increases with aging in elderly women with fracture, and suggest that a decrease in bone mass of elderly women may be due to an increase in osteoclast population associated with aging.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297335     DOI: 10.1016/s0047-6374(02)00071-4

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  10 in total

1.  Groove structure of porous hydroxyapatite scaffolds (HAS) modulates immune environment via regulating macrophages and subsequently enhances osteogenesis.

Authors:  Chenglong Li; Lu Yang; Xiaohua Ren; Mu Lin; Xiliang Jiang; Daonan Shen; Taotao Xu; Jing Ren; Lijuan Huang; Wei Qing; Jiajun Zheng; Yandong Mu
Journal:  J Biol Inorg Chem       Date:  2019-07-19       Impact factor: 3.358

2.  Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate.

Authors:  Behnam Eslami; Shuanhu Zhou; Inge Van Eekeren; Meryl S LeBoff; Julie Glowacki
Journal:  Calcif Tissue Int       Date:  2011-02-15       Impact factor: 4.333

3.  Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.

Authors:  Anaïs Marie Julie Møller; Jean-Marie Delaissé; Jacob Bastholm Olesen; Jonna Skov Madsen; Luisa Matos Canto; Troels Bechmann; Silvia Regina Rogatto; Kent Søe
Journal:  Bone Res       Date:  2020-07-01       Impact factor: 13.567

4.  Effect of age on regulation of human osteoclast differentiation.

Authors:  Ping-Lin Chung; Shuanhu Zhou; Behnam Eslami; Longxiang Shen; Meryl S LeBoff; Julie Glowacki
Journal:  J Cell Biochem       Date:  2014-08       Impact factor: 4.429

5.  Mitochondrial dysfunction impairs osteogenesis, increases osteoclast activity, and accelerates age related bone loss.

Authors:  David J Deehan; Doug M Turnbull; Laura C Greaves; Philip F Dobson; Ella P Dennis; Daniel Hipps; Amy Reeve; Alex Laude; Carla Bradshaw; Craig Stamp; Anna Smith
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

6.  Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease.

Authors:  Anna Daroszewska; Lorraine Rose; Nadine Sarsam; Gemma Charlesworth; Amanda Prior; Kenneth Rose; Stuart H Ralston; Robert J van 't Hof
Journal:  Dis Model Mech       Date:  2018-08-23       Impact factor: 5.758

Review 7.  Aging and Mechanoadaptive Responsiveness of Bone.

Authors:  Behzad Javaheri; Andrew A Pitsillides
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.163

8.  Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.

Authors:  Anaïs Marie Julie Møller; Jean-Marie Delaissé; Jacob Bastholm Olesen; Jonna Skov Madsen; Luisa Matos Canto; Troels Bechmann; Silvia Regina Rogatto; Kent Søe
Journal:  Bone Res       Date:  2020-07-01       Impact factor: 13.567

9.  Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.

Authors:  Zhaofei Li; Yanfang Zhao; Zhu Chen; Jannet Katz; Suzanne M Michalek; Yuhong Li; Ping Zhang
Journal:  Mol Immunol       Date:  2021-07-16       Impact factor: 4.174

10.  IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse.

Authors:  Xiang Li; Zong-Yu Zhou; Yuan-Yuan Zhang; Hui-Lin Yang
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.